Study directory

Mental health studies with practical context.

Compare studies and check their requirements with the research team.

Back to overview

10612studies shown

Showing 5,341-5,352 of 10,612

Other study type icon

CompletedNCT00001772

Evaluation of people with Rapid Cycling Bipolarity (RCBD)

This summary needs review. Please check the official study record and contact the research team for details.

In United States

BipolarityObservational

Countries: United States
Sponsor: National Institute of Mental Health (NIMH)
Condition: Bipolarity

Behavioral study icon

CompletedNCT04517942

Evaluation of Peer-led EVERYbody Project

This summary needs review. Please check the official study record and contact the research team for details.

In United States

Eating disordersBehavioralOver 18 Years

Countries: United States
Sponsor: Western Washington University
Condition: Eating disorders

Behavioral study icon

CompletedNCT02627612

Evaluation of ProVetus/Sponsorship Initiative

This summary needs review. Please check the official study record and contact the research team for details.

In United States

PTSDBehavioralOver 18 Years

Countries: United States
Sponsor: Teachers College, Columbia University
Condition: PTSD

Behavioral study icon

CompletedNCT05035927

Evaluation of Psilocybin (TRP-8802) in the Treatment of Binge Eating disorders

This summary needs review. Please check the official study record and contact the research team for details.

In United States

Eating disordersBehavioralFrom 18 Years to 64 Years

Countries: United States
Sponsor: TRYP Therapeutics
Condition: Eating disorders

Drug study icon

CompletedNCT04661514

Evaluation of Psilocybin in Eating disorders: Safety and Efficacy

This summary needs review. Please check the official study record and contact the research team for details.

In United States

Eating disordersDrugFrom 18 Years to 40 Years

Countries: United States
Sponsor: University of California, San Diego
Condition: Eating disorders

Behavioral study icon

CompletedNCT02486705

Evaluation of PTSD Family Coach, a Mobile Phone App for Family Members of Individuals With PTSD

This summary needs review. Please check the official study record and contact the research team for details.

Remote / online

PTSDBehavioralOver 18 Years

Countries: United States
Sponsor: VA Palo Alto Health Care System
Condition: PTSD

Device study icon

CompletedNCT00001545

Evaluation of Repetitive Transcranial Magnetic Stimulation (rTMS) in the Treatment of Mood Disorders

This summary needs review. Please check the official study record and contact the research team for details.

In United States

Bipolarity, DepressionDeviceFrom 18 Years to 90 Years

Countries: United States
Sponsor: National Institute of Mental Health (NIMH)
Condition: Bipolarity, Depression

Behavioral study icon

Active Not RecruitingNCT05384223

Evaluation of RRFT for Co-occurring SUD and PTSD Among Teens

This summary needs review. Please check the official study record and contact the research team for details.

In United States

PTSD, AddictionBehavioralFrom 13 Years to 75 Years

Countries: United States
Sponsor: Medical University of South Carolina
Condition: PTSD, Addiction

Drug study icon

CompletedNCT03247556

Evaluation of SPN-812 (Viloxazine Extended-release Capsule) High Dose in Adolescents With ADHD

This summary needs review. Please check the official study record and contact the research team for details.

In United States

ADHDDrugFrom 12 Years to 17 Years

Countries: United States
Sponsor: Supernus Pharmaceuticals, Inc.
Condition: ADHD

Drug study icon

CompletedNCT03247543

Evaluation of SPN-812 (Viloxazine Extended-release Capsule) High Dose in Children With ADHD

This summary needs review. Please check the official study record and contact the research team for details.

In United States

ADHDDrugFrom 6 Years to 11 Years

Countries: United States
Sponsor: Supernus Pharmaceuticals, Inc.
Condition: ADHD

Drug study icon

CompletedNCT04016779

Evaluation of SPN-812 (Viloxazine Extended-release Capsule) in Adults With ADHD

This summary needs review. Please check the official study record and contact the research team for details.

In United States

ADHDDrugFrom 18 Years to 65 Years

Countries: United States
Sponsor: Supernus Pharmaceuticals, Inc.
Condition: ADHD

Drug study icon

CompletedNCT03247517

Evaluation of SPN-812 (Viloxazine Extended-release Capsule) Low Dose in Adolescents With ADHD

This summary needs review. Please check the official study record and contact the research team for details.

In United States

ADHDDrugFrom 12 Years to 17 Years

Countries: United States
Sponsor: Supernus Pharmaceuticals, Inc.
Condition: ADHD

Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.